Related Experiment Video
Updated: Jul 28, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
Published on: October 30, 2016
Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
Tonie E Rocke1, F Joshua Dein, Martina Fuchsberger
1USGS National Wildlife Health Center, 6006 Schroeder Road, Madison, WI 53711, USA. tonie_rocke@usgs.gov
Abstract:
A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of Yersinia pestis for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.
Insights
A laboratory accident exposed a person to a recombinant raccoon poxvirus (RCN) vaccine vector. The patient developed a lesion and antibodies, marking the first documented human exposure to RCN.
Area of Science:
- * Virology and Vaccinology
- * Zoonotic Disease Research
Background:
- * Development of recombinant raccoon poxvirus (RCN) as a vaccine vector for Yersinia pestis antigens.
- * Intended use for protecting wild rodents and other animals against plague.
Observation:
- * A laboratory accident led to accidental human exposure to the RCN vaccine vector.
- * The patient developed a localized skin lesion (blister) at the exposure site.
- * The lesion appeared within 9 days and resolved within 4 weeks.
Findings:
- * Raccoon poxvirus (RCN) was successfully cultured from the patient's lesion.
- * The patient developed antibodies against both the plague antigen (F1) and the RCN vector.
- * This case represents the first documented instance of human exposure to RCN.
Implications:
- * Demonstrates the potential for zoonotic transmission of RCN from animal vaccine vectors to humans.
- * Highlights the importance of biosafety protocols when working with novel viral vectors.
- * Provides valuable data on the host response to RCN infection in humans.
Related Concept Videos
Viral Recombination
Smallpox
Chickenpox
Rabies

